Preclinical research is used to investigate the biological effects of Heel medicines.
Because Heel drugs are combinations of natural active ingredients designed to act on multiple targets, their modes of action are much broader than those of synthetic drugs.
We use modern technologies – amongst others also transcriptomics – to explore biological activity. This is an excellent method for investigating the effects of our multi-target drugs.
Research work involving internationally standardized technology platforms provides insights into the biological properties of our drugs from the perspective of systems biology. Independent international research laboratories have reported significant results using these modern laboratory methods. The study results are presented at scientific conferences, where they have attracted considerable interest, and are published in respected peer reviewed scientific journals.
